Literature DB >> 2223683

Hormone implants and tachyphylaxis.

T Garnett1, J W Studd, A Henderson, N Watson, M Savvas, A Leather.   

Abstract

The serum oestradiol levels of 1388 women treated with hormone implants at a menopause clinic were reviewed in 1988. Thirty-eight (3%) were found to be above 1750 pmol/l. Of these 38 women with supraphysiological oestradiol levels 23 had started therapy for menopausal symptoms and 15 for the premenstrual syndrome (PMS). Of the 23 women treated for menopausal symptoms 11 had a history of psychiatric referral for depression and nine had undergone a surgical menopause. Nine of the 15 women with PMS had a history of psychiatric referral for depressive symptoms. We conclude that the women who attain supraphysiological levels of oestradiol on implant therapy have a high frequency of psychopathology or surgical menopause and may require higher oestradiol levels for adequate control of symptoms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2223683     DOI: 10.1111/j.1471-0528.1990.tb02447.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  4 in total

Review 1.  Postmenopausal hormone replacement therapy.

Authors:  H S Jacobs; F E Loeffler
Journal:  BMJ       Date:  1992-12-05

2.  Complications of hormone replacement therapy in post-menopausal women.

Authors:  J Studd
Journal:  J R Soc Med       Date:  1992-07       Impact factor: 5.344

Review 3.  Hormone replacement therapy in the aged. A state of the art review.

Authors:  S Jacobs; T C Hillard
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 4.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.